Emergent BioSolutions (EBS) Raw Materials (2011 - 2018)

Emergent BioSolutions' Raw Materials history runs 8 years deep, the most recent figure standing at $51.8 million for Q4 2018.

• In Q4 2018, Raw Materials rose 43.49% year-over-year to $51.8 million; the TTM figure through Dec 2018 stood at $51.8 million (up 43.49% YoY), while the FY2018 annual figure was $51.8 million, up 43.49% from the prior year.
• Raw Materials was $51.8 million for Q4 2018 at Emergent BioSolutions, up from $33.8 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $51.8 million in Q4 2018 to a low of $15.0 million in Q2 2014.
• Historically, Raw Materials has averaged $27.5 million across 5 years, with a median of $29.3 million in 2016.
• The sharpest annual moves came in 2014 and 2015: Raw Materials jumped 614.81% in 2014, then fell 7.19% in 2015.
• A 5-year view of Raw Materials shows it stood at $17.4 million in 2014, then climbed by 22.45% to $21.3 million in 2015, then soared by 44.24% to $30.7 million in 2016, then climbed by 17.64% to $36.1 million in 2017, then jumped by 43.49% to $51.8 million in 2018.
• The last three Raw Materials figures came in at $51.8 million (Q4 2018), $33.8 million (Q3 2018), and $34.4 million (Q2 2018), per Business Quant data.